540729 — Vanta Bioscience Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Vanta Bioscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	PRESS	ARS	PRESS
Standards:	IAS	IAS	—	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	141	100	96.9	62.8	97.2
Cost of Revenue
Gross Profit	130	92.2	89.9	53.3	90
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	110	72.9	75.4	113	129
Operating Profit	31.8	27.5	21.5	-50.6	-31.8
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	13.4	5.89	2.28	-103	-88.3
Provision for Income Taxes
Net Income After Taxes	10.1	4.48	0.882	-104	-86.1
Minority Interest
Net Income Before Extraordinary Items
Net Income	10	4.5	0.882	-64.8	-23.2
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10	4.5	0.882	-64.8	-23.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.59	0.686	0.14	-10.3	-3.67